Next Article in Journal
Preclinical Therapeutic Assessment of a New Chemotherapeutics [Dichloro(4,4’-Bis(2,2,3,3-Tetrafluoropropoxy) Methyl)-2,2’-Bipryridine) Platinum] in an Orthotopic Patient-Derived Xenograft Model of Triple-Negative Breast Cancers
Previous Article in Journal
Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(4), 837; https://doi.org/10.3390/pharmaceutics14040837
Action Date Notes Link
article pdf uploaded. 11 April 2022 14:05 CEST Version of Record https://www.mdpi.com/1999-4923/14/4/837/pdf-vor
article xml file uploaded 12 April 2022 11:24 CEST Original file -
article xml uploaded. 12 April 2022 11:24 CEST Update -
article pdf uploaded. 12 April 2022 11:24 CEST Updated version of record https://www.mdpi.com/1999-4923/14/4/837/pdf-vor
article supplementary file uploaded. 12 April 2022 11:24 CEST - https://www.mdpi.com/1999-4923/14/4/837#supplementary
article html file updated 12 April 2022 11:26 CEST Original file -
article xml file uploaded 14 April 2022 07:55 CEST Update -
article xml uploaded. 14 April 2022 07:55 CEST Update https://www.mdpi.com/1999-4923/14/4/837/xml
article pdf uploaded. 14 April 2022 07:55 CEST Updated version of record https://www.mdpi.com/1999-4923/14/4/837/pdf
article html file updated 14 April 2022 07:57 CEST Update -
article html file updated 2 August 2022 18:17 CEST Update https://www.mdpi.com/1999-4923/14/4/837/html
Back to TopTop